We’re delighted to share that Andrea Kasinski, PICR Deputy Director and professor of Biological Sciences, has received the 2025 Cancer Research Award from the Lafayette @lionsclubs.
The award recognizes her outstanding contributions to cancer research and her leadership in bridging the gap between discovery and real-world impact.
Thank you to the Lafayette Lions Club for supporting #PurdueCancerResearch and the scientists driving innovation to improve health for our #Indiana communities and beyond. 💛
It was an absolute honor to present my work at AACR 2025!
This incredible opportunity would not have been possible without the support and guidance of my amazing PI, Dr.@AndreaKasinski for whom I am truly grateful!
Enjoying #AACR25 with the full lab. Looking forward to a talk later today by @PiltanSamira from the lab on her work on RNA loading into EVs using a highly conserved motif. @PUCancerInst @Research_Purdue @PurdueBiolSci
Purdue proudly honored researchers at the Seed for Success Acorn Awards for securing $1 million+ in external funding for a single proposal 🌟 Congratulations to all recipients!
Read here: https://t.co/7Lxj3eMio6
#PurdueResearch#Purduebiology#purduescience
Our much-anticipated manuscript on a fully-modified version of miR-34a. When delivered via a ligand, it has sustained silencing activity leading to complete cures in some mice. Outstanding work by 1st author @AhmedMaAbdelaal@PUCancerInst@PurdueBiolSci https://t.co/5Ee5AxP4c2
I am thrilled to share our latest work in targeted cancer therapy, describing development of a microRNA with outstanding stability and activity, and its tumor targeting. This exceptional work deserves an X-editorial (it's a tweetorial!), so here it is:
https://t.co/Bv2lcW3ZYf
~1
Press release highlighting our recent successes using the 1st fully-modified miR-34a, conjugated to folate as an anti-cancer agent. Outstanding work by 1st author @AhmedMaAbdelaal co-corresponding author @ikjot_sohal & others. @PurdueBiolSci@PUCancerInst https://t.co/w3lTtTOxB1
An amazingly interesting paper from @AhmedMaAbdelaal in our lab! 🤩 Using a fully-modified miR-34a with a ligand has a sustained activity for >120 hours! Please take a look. Looking forward to testing the effects in clinical setting.
https://t.co/xxpFLJhPZi
A much-anticipated review on H4K20me3 from the talented @aagredom A beautiful overview of this modification and the enzymes responsible (KMT5Cand others), a modification that does not get nearly enough attention.
https://t.co/RYinDHIrVx
Happy to highlight a beautiful review of extracellular vesicles written by @ikjot_sohal. It covers various classes of EVs and their reported roles in cancer.
https://t.co/uQjLW32x9S